In Rwanda, malaria is one of the primary causes of
death for under-5s
HLSP is committed to using its established expertise in both health
systems development and public health to improve global and country
responses in communicable disease control (CDC) as part of the
wider process of achieving the Millennium Development Goals
(MDGs).
The MDGs set challenging global communicable disease targets for
countries and development partners to reduce the incidence of
malaria, tuberculosis (TB) and rotavirus (diarrhoea and vomiting in
very young children) by 2015. HLSP provides both technical and
managerial support to strengthen the links between public health
policy, best practice in CDC programmes, including their
integration into wider health systems.
HLSP key strength is its ability to provide technical advice
both in communicable disease control and health systems development
based on over twenty years experience in over 100 countries.
In many regions, the private sector has an increasing role in
providing communicable disease services. HLSP advocates and
supports the development of stronger government stewardship in
setting and monitoring standards of care and engagement of the
private sector – through programmes such as social marketing of
Insecticide Treated Nets (ITNs) to reduce the transmission of
malaria and franchising to improve the quality of drugs directly
purchased from private sector providers.
In addition to the established major global diseases, HLSP is
providing support to private sector partners on emergent
communicable diseases such as Avian Influenza and Severe Acute
Respiratory Syndrome (SARS) in an effort to reduce transmission,
understand the risks and contribute to an informed debate about
their potential impact.
